Cardiac Tissue Engineering Market Values: Region-by-Region Breakdown
The global cardiac tissue engineering market is expanding as regenerative medicine, 3D bioprinting, and advanced cell-based technologies create new possibilities for cardiovascular care. The market was valued at US$546.8 million in 2023, reached US$621.2 million in 2024, and is projected to reach US$1,333.6 million by 2029, registering a CAGR of 16.5% from 2024 to 2029.
Market growth is driven by...
30 Leading Peptide Synthesis Companies Shaping Innovation and Market Growth to 2031
The global peptide synthesis market is projected to grow from USD 0.98 billion in 2026 to USD 1.54 billion by 2031, at a CAGR of 9.5% during the forecast period. The market was valued at USD 0.91 billion in 2025.
Growth in the peptide synthesis market is being driven by the expanding peptide therapeutics pipeline, rapidly increasing demand for GLP-1 and other metabolic peptides, growing development...
32 Leading Lab Automation Companies Shaping Innovation and Market Growth to 2031
The global lab automation market is transforming laboratory operations through automated liquid handling, robotic systems, laboratory information management systems, integrated workstations, microplate readers, and connected software platforms. Growing demand for high-throughput screening, improved laboratory efficiency, reduced manual errors, and advances in robotics, artificial intelligence, and...
Bioconjugation Market Values: Region-by-Region Breakdown
The global bioconjugation market is expanding rapidly as advancements in drug development, targeted therapeutics, and precision medicine reshape the biopharmaceutical industry. The market is projected to reach USD 10.86 billion by 2029, up from an estimated USD 5.27 billion in 2024, registering a CAGR of 15.6% during the forecast period.
The growing adoption of advanced bioconjugation technologies...
Leading Cancer Diagnostics Companies Shaping Innovation and Market Growth to 2031
The global cancer diagnostics market is projected to grow from USD 29.86 billion in 2026 to USD 44.92 billion by 2031, at a CAGR of 7.0% during the forecast period. The market was valued at USD 27.62 billion in 2025.
The rising global burden of cancer, coupled with increasing awareness of the importance of early detection and timely diagnosis, is a major factor driving demand for cancer diagnostics....
Histology Market to Reach USD 14.5 Billion by 2031
The global Histology Market is projected to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, registering a CAGR of 10.2% during the forecast period. Market growth is being driven by the increasing global burden of cancer and chronic diseases, rising adoption of precision medicine, growing demand for biomarker-driven disease characterization, and investments in advanced pathology...
GLP-1 Medications: Market Growth, Manufacturing Opportunities, and the Future of Obesity Care
The growing adoption of GLP-1 medications is reshaping the pharmaceutical and healthcare industries. Originally developed primarily for type 2 diabetes management, GLP-1 therapies have expanded into obesity and broader cardiometabolic care, creating significant opportunities for pharmaceutical companies, contract manufacturers, healthcare providers, and other industry stakeholders.
According...
Veterinary Medicine: Market Trends, Innovations, and Opportunities in Animal Healthcare
Veterinary medicine is becoming an increasingly important part of the global healthcare and animal production ecosystem. From companion animal care to livestock health management, advances in diagnostics, vaccines, pharmaceuticals, and preventive healthcare are changing how animal diseases are managed.
The growing focus on animal welfare, disease prevention, food security, and zoonotic disease...
mHealth Solutions Market to Reach USD 275.44 Billion by 2031
The global mHealth Solutions Market is projected to reach USD 275.44 billion by 2031, up from USD 109.05 billion in 2026, registering a CAGR of 20.4% during the forecast period. Market growth is being driven by the digitalization of healthcare systems, increasing smartphone and internet penetration, rising chronic disease prevalence, growing adoption of connected medical...
ASEAN Rapid Diagnostic Test Market to Reach USD 1.36 Billion by 2030
The ASEAN Rapid Diagnostic Test Market is valued at an estimated USD 1.08 billion in 2025 and is projected to reach USD 1.36 billion by 2030, registering a CAGR of 4.7% during the forecast period. Market growth is being driven by the rising prevalence of chronic and infectious diseases, increasing adoption of Point of Care Testing, growing demand for Rapid...